Yarlagadda S. Babu, Senior VP - Drug Discovery at BIOCRYST PHARMACEUTICALS INC (BCRX), bought 25,000 shares at $1.45 ($36K) on 2019-11-18, disclosed to the SEC on 2019-11-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| BCRX | SELL | 2021-12-09 | $367K | — | Filing → |
| BCRX | SELL | 2016-08-29 | $244K | — | Filing → |
| BCRX | SELL | 2015-03-20 | $123K | — | Filing → |